News

BioSpace51m
Analysts Home In on Safety as Novo, Lilly, Amgen Highlight Weight Loss Data at ADA
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
Eli Lilly to roll out diabetes medicine in prefilled pen
Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The ...
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Eli Lilly isn't a one-trick pony. The company's lineup of approved medicines features blockbusters like Verzenio, a cancer ...
BioSpace2d
Lilly’s Antibody Protects Patients From Losing Muscle While Taking Novo’s Wegovy
Eli Lilly's bimagrumab led to weight loss that was due almost entirely to fat reduction when combined with semaglutide, ...
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
India Today on MSN2d
Wegovy and Lilly's bimagrumab combo shows weight loss without muscle loss
A new study finds combining bimagrumab with Wegovy leads to significant fat loss without muscle loss. This breakthrough ...